Abstract
Many mesenchymal stem cell (MSC)-based clinical trials are targeted toward cardiovascular diseases, specifically cardiac ischemia. Investigatory work has revealed that MSC-produced “exosomes” are in fact the element that initiates tissue restoration. This, in addition to the advantages of using exosomes over transplanting whole cells, makes “MSC-exosome-based therapy” a very appealing concept. This review will discuss exosomes and their possible clinical applications, with particular emphasis on MSC-derived exosomes and their use in managing ischemic myocardial damage.
Downloads
Download data is not yet available.
How to Cite
Al-Sowayan, B. (2017). The Use of Exosomes in Clinical Applications, With an In-Depth Look at Those Derived From Mesenchymal Stem Cells and Their Use in Myocardial Regeneration. International Journal of Innovative Research in Medical Science, 2(09), 1295 to 1303. https://doi.org/10.23958/ijirms/vol02-i09/11
Copyrights & License
Copyright © 2017 Batla Al-Sowayan this is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This work is licensed under a Creative Commons Attribution 4.0 International License.
